MCHP News & Events

Catch up on the top artificial intelligence news and commentary by Wall Street analysts on publicly traded companies in the space with this daily recap compiled by The Fly.IPO FILING:OpenAI has confidentially filed for an IPO with the SEC, which allows the company to submit its financials to regulators for review before they're made available to the public, CNBC.com's Ashley Capoot reports. Anthropic and OpenAI could be in a race to go public due to the massive amount of capital they're trying to raise, the report states.STRICTER EXPORT CONTROLS:Taiwan authorities are planning much stricter export controls on AI chip sales to China to further align with U.S. measures, Bloomberg's Mackenzie Hawkins and Debby Wu, citing people familiar with the matter. Publicly traded companies in the space include AMD, Intel, Marvell, Microchip, Micron, Nvidia, Qualcommand Texas Instruments.MYTHOS-LEVEL AI MODEL:Anthropic is launching Claude Fable 5: a Mythos-class model that the company has made safe for general use. "Fable 5's capabilities exceed those of any model we've ever made generally available. It is state-of-the-art on nearly all tested benchmarks of AI capability, showing exceptional performance in software engineering, knowledge work, vision, scientific research, and many other areas. The longer and more complex the task, the larger Fable 5's lead over our other models," Anthropic said."Releasing a model this capable comes with risks. Without safeguards, Fable 5's capabilities in areas like cybersecurity could be misused to cause serious damage. We've therefore launched the model with safeguards that mean queries on some topics will instead receive a response from our next-most-capable model, Claude Opus 4.8. To release the model both safely and quickly, we've tuned these safeguards conservatively-they'll sometimes catch harmless requests, though they trigger, on average, in less than 5% of sessions. With more capable models arriving in the coming months, we're working to improve our safeguards and reduce false positives as quickly as we can."For a small group of cyberdefenders and infrastructure providers, the company is also launching Claude Mythos 5. It's the same underlying model as Fable 5, but with the safeguards lifted in some areas. Mythos 5 will initially be deployed through Project Glasswing, in collaboration with the U.S. Government, as an upgrade to Claude Mythos Preview. It has the strongest cybersecurity capabilities of any model in the world. Soon, it intends to expand access to Mythos 5 through a broader trusted access program.PHYSICAL AI LIVING LAB:Nebiusannounced the Physical AI Living Lab, a six-month program that equips British and European robotics startups with Nvidia'sphysical AI development tools and Nebius's AI cloud infrastructure. The Lab builds on Nebius and Nvidia's collaboration to create a cloud platform for robotics and physical AI. The companies intend to extend the Physical AI Living Lab to other regions over time and bring in further cohorts as the program grows.

Microchip Technology's Armenian office has received approval from the U.S. Department of Commerce's Bureau of Industry and Security, or BIS, for an export license authorizing the use of advanced technology and related high-performance hardware. Such authorization requires companies to demonstrate compliance with U.S. export regulations, including clear definition of permitted end uses, controlled access to sensitive technology and internal compliance safeguards. The license enables Microchip to securely and responsibly develop advanced semiconductor technologies in Armenia within the global regulatory framework. The authorization allows approved Armenia-based personnel to access and work with specified controlled technology for authorized research and development programs, subject to U.S. export-control regulations, Microchip's internal compliance processes, technology-control procedures, training requirements and access restrictions. "As the only multinational semiconductor company in Armenia to receive a site license from BIS, this approval highlights our commitment to high-value semiconductor innovation through strong global operations and solidifies our support of the region's rapidly growing technology ecosystem," said Shakeel Peera, vice president of Microchip's FPGA business unit. "The license enables our Armenia engineering team to participate in the development of advanced FPGA technologies while meeting the rigorous compliance standards required for controlled engineering work."

Stock futures are modestly lower this morning after the S&P 500, Nasdaq, and Dow all closed at record highs on Monday. Investors are seemingly taking a cautious stance ahead of this week's labor-market data and additional comments from Federal Reserve officials.The market received another boost from strong technology-related news. Hewlett Packard Enterprise surged in premarket trading after raising financial targets, while AI-linked names such as Marvell and Nvidia also attracted buying interest. Enthusiasm surrounding data centers, AI infrastructure, and enterprise spending continues to provide the primary source of market leadership.Bond yields remain elevated but relatively stable. The 10-year Treasury yield is hovering around the mid-4.4% range. Investors are watching whether upcoming economic data can support the soft-landing narrative without reigniting inflation fears. The JOLTS job openings report is also in focus.In pre-market trading, S&P 500 futures fell 0.17%, Nasdaq futures fell 0.03% and Dow futures fell 0.49%.Check out this morning's top movers from around Wall Street, compiled by The Fly.HIGHER -Marvellup 18% after NvidiaCEO Jensen Huang said at Computex Week in Taipei that the company is set to be the "next trillion-dollar company"Aveannaup 9% after raising its full-year outlook following completion of the acquisition of Family First HoldingMicrochipup 8% after FY26 data center solution revenue pre-announcementUP AFTER EARNINGS -HPEup 27%Citi Trendsup 10%Signet Jewelersup 7%Dollar Generalup 4%Donaldsonup 2%DOWN AFTER EARNINGS -Odditydown 19%Credo Technologydown 3%LOWER -Fulcrum Therapeuticsdown 51% after announcing the discontinuation of its pociredir program for the treatment of sickle cell disease and the initiation of a review of strategic alternativesPhilip Morrisdown 1% after cutting its full-year EPS view